Sunday, November 1, 2026

48 Top Stock Pitches (26th-1st November) [NO PAYWALL] 🖨️

Capital Employed rounds up 48 stock pitches, led by Greystone’s $14.50 target for organ-transplant logistics firm Strata Critical Medical, versus $4.70.

SRTA $427M

Capital Employed 26h ago 11 clicks

33h ago AEYE $132M

Idea Brunch with Jamil Tahir of TurnMark Capital

Sunday's Idea Brunch 2 clicks

36h ago CLMT $4.3B

Portfolio Update: October 2026 + Q3 Earnings outlook

Treasure Hunting 2 clicks

From X

@valuedontlie Oct 30

Colin King on X

SOTP idea $MGM https://t.co/6R80w4hHmB

@hntrbrkmedia Oct 30

Hunterbrook on X

Based on Hunterbrook Media’s reporting, at the time of publication Hunterbrook Capital is short $BE. Positions may change at any time. This thread is not investment advice or any recommendation. See full disclosures on our website.

@hntrbrkmedia Oct 30

Hunterbrook on X

UPDATE: Remember when Bloom claimed its supply chain is “not dependent on China” after Hunterbrook’s reporting? New trade records show $BE seems to have quietly restarted a Chinese supply route for scandium-containing fuel cell parts. https://t.co/BUAGun5iAR

@absreturnchaser Oct 30

absreturnchaser on X

@bcanet @Randall7575 @essential6t7 Plenty of PMs who think $WU Western Union wouldn't mind getting out of the deal and Board occupied selling $WU itself post-offer. @bharringtonw11 reported on it.

@DOMOCAPITAL Oct 30

DOMO Capital Management, LLC on X

I expect an earnings beat against analyst estimates. The price of ethanol rocketed during the quarter, and I don't think the market or analysts understand how the $ALTO hedging works on their specialty alcohols. No one noticed by Q2, despite being amazing, was adversely impacted due to this and EPS should have been higher than reported. Q3 should benefit where Q2 was hurt and EPS are likely to be higher than they should be as compared to Adjusted EBITDA.

@negligible_cap Oct 30

Negligible Capital on X

I know $AMZN hates raising equity (hasn’t done so since their 1997 IPO) but this from Jassy feels a lot like something someone would say before an equity raise https://t.co/CKToF9r21B

@leevalueroach Oct 30

Lee Roach on X

Lets just say my wife was never excited about my $HOG

@DeepSailCapital Oct 30

Deep Sail Capital on X

$HTZ - Borrow still incredibly tight. Moving a bit this morning.

Travelzoo ($TZOO): Members Pay Up Front, GAAP Calls It a Loss, and the Market Prices It Like It's Dying. I think the stock can 4x

Travelzoo’s roughly 400,000 prepaid members generate deferred revenue while acquisition costs hit GAAP earnings immediately, masking the…

TZOO $53M

Calvin Blissett 36h ago 1 click

Altria: Dutiful

Altria raised 2026 adjusted EPS guidance to $5.66 to $5.74 and authorized more buybacks, while on! loses share as cigarette margins hold.

MO $130B

Invariant 36h ago 1 click

Sleep Well Portfolio (Oct 2026) - SWI#25 and #26 Adding Exposure to AI.

Sleep Well Portfolio adds two AI infrastructure suppliers and trims CrowdStrike at a 140x free-cash-flow valuation and $270 billion market…

CRWD $267BSE $45B

Sleep Well Investments 37h ago 6 clicks

Portfolio Update October 2026

Portfolio returned over 15% in October, lifting cumulative gains to 103.5%, while adding 3i Group and increasing Floor & Decor and…

TGOPF $32BTSCO $17B

D Invests 41h ago 3 clicks

When the liquidity does not add up

Arbor Realty Trust’s dividend suspension is presented as creating $60 million of liquidity, raising questions about its ability to meet…

ABR $2.2B

John Hempton's Newsletter Oct 31 3 clicks

Amazon.com Inc (AMZN) Earnings Update: Q3 2026

Amazon reported Q3 2026 net sales up 12% year over year to $201.9 billion, narrowly below the $202.3 billion consensus estimate.

AMZN $2.6T

SixSigmaCapital: Navigating the Financial Markets Oct 31 7 clicks

Expert Call | Optical Module Ramps, Lumentum vs. Coherent Momentum, Server CPU, and Advanced Packaging Constraints

AAOI, Lumentum and Coherent 800G ramps, NVIDIA Rubin timing, and AMD, Intel and Arm server CPU demand frame an expert call on AI…

LITE $83BCOHR $47B

P Equity Research Oct 31 1 click

Verra veerer

Verra Mobility’s Avis termination threatens 2027 earnings, while Government Solutions profit rose 25% and implied fourth-quarter guidance…

VRRM $505M

The Oak Bloke Oct 31 2 clicks

FTAI 3Q26: Aero margins in focus

FTAI’s Aerospace Products margin rebounded to 31% as CFM56 module output rose, while Power deposits and contracted deliveries fund its 2027…

FTAI $16B

Stock Thoughts Oct 31 4 clicks

Microsoft's AI Boom Has A Cost

Microsoft’s Azure grew 48% as AI monetization accelerated, but doubled CapEx, largely for CPUs and GPUs, reduced quarterly free cash flow…

MSFT $3.9T

Yiannis Zourmpanos Oct 31 2 clicks

T · short

At&t INC

AT&T’s stalled deleveraging and share repurchase case has prompted a bearish turn on the telecom stock.

T $144B

Value Investors Club Aug 3

Alphabet: Market Misunderstanding Is Baffling, But Don't Be Fooled

Alphabet trades below 20x forward earnings after a 30% drop from 2026 highs, while 31.8% operating margins and AI capex frame the…

GOOGL $4T

JR Research Oct 31 1 click

Life360 ($LIF): The Family App Wall Street Fell Out of Love With

Life360 has fallen 60% despite 40% revenue growth, 100 million monthly users and profitability, as its family-safety subscriptions and…

LIF $3.6B

Substack von Philipp Oct 31 3 clicks

Anthropic’s Growth is Slowing: Is AI Capex Next? | The Weekly Wrap

Anthropic’s revenue growth slowed from 147% in Q2 to 45% in Q3, raising questions about AI capital spending as Amazon holds capex flat.

AMZN $2.6T

Steve Eisman Oct 30 5 clicks

American Tower's Starlink Opportunity

American Tower could gain $1.13 to $3.54 in AFFO per share if Starlink accesses 80,000 U.S. cell sites and becomes a fourth major tenant.

AMT $88B

Dane Bowler Oct 30 3 clicks

CVX Earnings Review

Chevron’s Q3 revenue rose 35% to $65.2 billion and EBITDA 75% to $20.2 billion, while production trailed guidance and refining margins…

CVX $465B

Cestrian Capital Research Oct 30 3 clicks

AstraZeneca (AZN) Q3 FY12/26 Earnings Review

AstraZeneca reported $16.2 billion Q3 revenue, up 7%, as oncology grew 17% and Farxiga fell 25% after US generics.

AZN $270B

Cestrian Capital Research Oct 30 2 clicks

SNY Earnings Review

Sanofi raised FY26 guidance after Q3 sales grew 14.3% at constant currency, led by 34.8% Dupixent growth; vaccines declined 6.6%.

SNY $108B

Cestrian Capital Research Oct 30 1 click

SK hynix: Despite Their Premium To The Korean Shares, The U.S. ADRs Are A Bargain

SK hynix's U.S. ADR trades at a valuation discount despite AI-driven memory demand, with 50% of 2027–2028 capacity under long-term…

SKHY $806B

Adam Schadt Oct 30 2 clicks

Bloom: Chinese Scandium Supply Route Restarts

Bloom may have reopened imports of scandium-containing components from China to the United States, according to new trade data.

BE $67B

Hunterbrook Oct 30 4 clicks

Sunday, November 1, 2026

Colin King on X

Hunterbrook on X

Hunterbrook on X

absreturnchaser on X

DOMO Capital Management, LLC on X

Negligible Capital on X

Lee Roach on X

Deep Sail Capital on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 67 of 268

X accounts we follow

Investor letters we follow

Sectors